Semaglutide Showcases Promise in Treating Fatty Liver Disease
A recent phase 3 clinical trial has found that semaglutide, a key component of weight loss and diabetes medications like Ozempic and Wegovy, can effectively treat a serious form of fatty liver disease. The study involved 800 participants and lasted 72 weeks. The results showed that nearly two-thirds of patients given the semaglutide treatment experienced … Read more